Cargando…

Cytostasis and morphological changes induced by mifepristone in human metastatic cancer cells involve cytoskeletal filamentous actin reorganization and impairment of cell adhesion dynamics

BACKGROUND: Changes in cell shape and plasticity in cytoskeletal dynamics are critically involved in cell adhesion, migration, invasion and the overall process of metastasis. Previous work in our laboratory demonstrated that the synthetic steroid mifepristone inhibited the growth of highly metastati...

Descripción completa

Detalles Bibliográficos
Autores principales: Brandhagen, BreeAnn N, Tieszen, Chelsea R, Ulmer, Tara M, Tracy, Maria S, Goyeneche, Alicia A, Telleria, Carlos M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562154/
https://www.ncbi.nlm.nih.gov/pubmed/23351358
http://dx.doi.org/10.1186/1471-2407-13-35
_version_ 1782258044057419776
author Brandhagen, BreeAnn N
Tieszen, Chelsea R
Ulmer, Tara M
Tracy, Maria S
Goyeneche, Alicia A
Telleria, Carlos M
author_facet Brandhagen, BreeAnn N
Tieszen, Chelsea R
Ulmer, Tara M
Tracy, Maria S
Goyeneche, Alicia A
Telleria, Carlos M
author_sort Brandhagen, BreeAnn N
collection PubMed
description BACKGROUND: Changes in cell shape and plasticity in cytoskeletal dynamics are critically involved in cell adhesion, migration, invasion and the overall process of metastasis. Previous work in our laboratory demonstrated that the synthetic steroid mifepristone inhibited the growth of highly metastatic cancer cells, while simultaneously causing striking changes in cellular morphology. Here we assessed whether such morphological alterations developed in response to cytostatic concentrations of mifepristone are reversible or permanent, involve rearrangement of cytoskeletal proteins, and/or affect the adhesive capacity of the cells. METHODS: Cancer cell lines of the ovary (SKOV-3), breast (MDA-MB-231), prostate (LNCaP), and nervous system (U87MG) were exposed to cytostatic concentrations of mifepristone and studied by phase-contrast microscopy. The transient or permanent nature of the cytostasis and morphological changes caused by mifepristone was assessed, as well as the rearrangement of cytoskeletal proteins. De-adhesion and adhesion assays were utilized to determine if mifepristone-arrested and morphologically dysregulated cells had abnormal de-adhesion/adhesion dynamics when compared to vehicle-treated controls. RESULTS: Mifepristone-treated cells displayed a long, thin, spindle-like shape with boundaries resembling those of loosely adhered cells. Growth arrest and morphology changes caused by mifepristone were reversible in SKOV-3, MDA-MB-231 and U87MG, but not in LNCaP cells that instead became senescent. All cancer cell types exposed to mifepristone displayed greatly increased actin ruffling in association with accelerated de-adhesion from the culture plate, and delayed adhesion capacity to various extracellular matrix components. CONCLUSIONS: Cytostatic concentrations of mifepristone induced alterations in the cellular structure of a panel of aggressive, highly metastatic cancer cells of different tissues of origin. Such changes were associated with re-distribution of actin fibers that mainly form non-adhesive membrane ruffles, leading to dysregulated cellular adhesion capacity.
format Online
Article
Text
id pubmed-3562154
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35621542013-02-05 Cytostasis and morphological changes induced by mifepristone in human metastatic cancer cells involve cytoskeletal filamentous actin reorganization and impairment of cell adhesion dynamics Brandhagen, BreeAnn N Tieszen, Chelsea R Ulmer, Tara M Tracy, Maria S Goyeneche, Alicia A Telleria, Carlos M BMC Cancer Research Article BACKGROUND: Changes in cell shape and plasticity in cytoskeletal dynamics are critically involved in cell adhesion, migration, invasion and the overall process of metastasis. Previous work in our laboratory demonstrated that the synthetic steroid mifepristone inhibited the growth of highly metastatic cancer cells, while simultaneously causing striking changes in cellular morphology. Here we assessed whether such morphological alterations developed in response to cytostatic concentrations of mifepristone are reversible or permanent, involve rearrangement of cytoskeletal proteins, and/or affect the adhesive capacity of the cells. METHODS: Cancer cell lines of the ovary (SKOV-3), breast (MDA-MB-231), prostate (LNCaP), and nervous system (U87MG) were exposed to cytostatic concentrations of mifepristone and studied by phase-contrast microscopy. The transient or permanent nature of the cytostasis and morphological changes caused by mifepristone was assessed, as well as the rearrangement of cytoskeletal proteins. De-adhesion and adhesion assays were utilized to determine if mifepristone-arrested and morphologically dysregulated cells had abnormal de-adhesion/adhesion dynamics when compared to vehicle-treated controls. RESULTS: Mifepristone-treated cells displayed a long, thin, spindle-like shape with boundaries resembling those of loosely adhered cells. Growth arrest and morphology changes caused by mifepristone were reversible in SKOV-3, MDA-MB-231 and U87MG, but not in LNCaP cells that instead became senescent. All cancer cell types exposed to mifepristone displayed greatly increased actin ruffling in association with accelerated de-adhesion from the culture plate, and delayed adhesion capacity to various extracellular matrix components. CONCLUSIONS: Cytostatic concentrations of mifepristone induced alterations in the cellular structure of a panel of aggressive, highly metastatic cancer cells of different tissues of origin. Such changes were associated with re-distribution of actin fibers that mainly form non-adhesive membrane ruffles, leading to dysregulated cellular adhesion capacity. BioMed Central 2013-01-26 /pmc/articles/PMC3562154/ /pubmed/23351358 http://dx.doi.org/10.1186/1471-2407-13-35 Text en Copyright ©2013 Brandhagen et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Brandhagen, BreeAnn N
Tieszen, Chelsea R
Ulmer, Tara M
Tracy, Maria S
Goyeneche, Alicia A
Telleria, Carlos M
Cytostasis and morphological changes induced by mifepristone in human metastatic cancer cells involve cytoskeletal filamentous actin reorganization and impairment of cell adhesion dynamics
title Cytostasis and morphological changes induced by mifepristone in human metastatic cancer cells involve cytoskeletal filamentous actin reorganization and impairment of cell adhesion dynamics
title_full Cytostasis and morphological changes induced by mifepristone in human metastatic cancer cells involve cytoskeletal filamentous actin reorganization and impairment of cell adhesion dynamics
title_fullStr Cytostasis and morphological changes induced by mifepristone in human metastatic cancer cells involve cytoskeletal filamentous actin reorganization and impairment of cell adhesion dynamics
title_full_unstemmed Cytostasis and morphological changes induced by mifepristone in human metastatic cancer cells involve cytoskeletal filamentous actin reorganization and impairment of cell adhesion dynamics
title_short Cytostasis and morphological changes induced by mifepristone in human metastatic cancer cells involve cytoskeletal filamentous actin reorganization and impairment of cell adhesion dynamics
title_sort cytostasis and morphological changes induced by mifepristone in human metastatic cancer cells involve cytoskeletal filamentous actin reorganization and impairment of cell adhesion dynamics
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562154/
https://www.ncbi.nlm.nih.gov/pubmed/23351358
http://dx.doi.org/10.1186/1471-2407-13-35
work_keys_str_mv AT brandhagenbreeannn cytostasisandmorphologicalchangesinducedbymifepristoneinhumanmetastaticcancercellsinvolvecytoskeletalfilamentousactinreorganizationandimpairmentofcelladhesiondynamics
AT tieszenchelsear cytostasisandmorphologicalchangesinducedbymifepristoneinhumanmetastaticcancercellsinvolvecytoskeletalfilamentousactinreorganizationandimpairmentofcelladhesiondynamics
AT ulmertaram cytostasisandmorphologicalchangesinducedbymifepristoneinhumanmetastaticcancercellsinvolvecytoskeletalfilamentousactinreorganizationandimpairmentofcelladhesiondynamics
AT tracymarias cytostasisandmorphologicalchangesinducedbymifepristoneinhumanmetastaticcancercellsinvolvecytoskeletalfilamentousactinreorganizationandimpairmentofcelladhesiondynamics
AT goyenechealiciaa cytostasisandmorphologicalchangesinducedbymifepristoneinhumanmetastaticcancercellsinvolvecytoskeletalfilamentousactinreorganizationandimpairmentofcelladhesiondynamics
AT telleriacarlosm cytostasisandmorphologicalchangesinducedbymifepristoneinhumanmetastaticcancercellsinvolvecytoskeletalfilamentousactinreorganizationandimpairmentofcelladhesiondynamics